Cargando…
Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling
Galectin-3 (Gal-3, LGALS3) is a pleotropic versatile, 29–35 kDa chimeric gene product, and involved in diverse physiological and pathological processes, including cell growth, homeostasis, apoptosis, pre-mRNA splicing, cell-cell and cell-matrix adhesion, cellular polarity, motility, adhesion, activa...
Autores principales: | Harazono, Yosuke, Kho, Dhong Hyo, Balan, Vitaly, Nakajima, Kosei, Hogan, Victor, Raz, Avraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637307/ https://www.ncbi.nlm.nih.gov/pubmed/26158764 |
Ejemplares similares
-
Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells
por: Harazono, Yosuke, et al.
Publicado: (2014) -
Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling()()
por: Nakajima, Kosei, et al.
Publicado: (2014) -
Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer
por: Zhang, Tianpeng, et al.
Publicado: (2015) -
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
por: Nakajima, Kosei, et al.
Publicado: (2020) -
Regulation of Tumor Progression by Extracellular Galectin-3
por: Nangia-Makker, Pratima, et al.
Publicado: (2008)